Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.
Saved in:
| Title: | Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone. |
|---|---|
| Authors: | Berkowitz SD; Colorado Prevention Center Clinical Research, Aurora, Colorado, USA.; Divisions of Cardiology and Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA., Bauersachs RM; Cardiovascular Center Bethanien CCB, Frankfurt, Germany.; Center of Thrombosis and Hemostasis, University of Mainz, Mainz, Germany., Szarek M; Colorado Prevention Center Clinical Research, Aurora, Colorado, USA.; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.; State University of New York Downstate Health Sciences University, Brooklyn, New York, USA., Nehler MR; Colorado Prevention Center Clinical Research, Aurora, Colorado, USA.; Division of Vascular Surgery, Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado, USA., Debus ES; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University of Hamburg-Eppendorf, Hamburg, Germany., Patel MR; Duke Clinical Research Institute, Durham, North Carolina, USA.; Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA., Anand SS; Department of Medicine & Epidemiology, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada., Capell WH; Colorado Prevention Center Clinical Research, Aurora, Colorado, USA.; Division of Endocrinology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA., Hess CN; Colorado Prevention Center Clinical Research, Aurora, Colorado, USA.; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA., Hsia J; Colorado Prevention Center Clinical Research, Aurora, Colorado, USA.; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA., Leeper NJ; Division of Vascular Surgery, Department of Surgery, Stanford University, Stanford, California, USA., Brasil D; FELUMA-Faculdade de Ciencias Medicas de Minas Gerais School of Medicine, Belo Horizonte, Brazil., Mátyás L; B-A-Z Central University Teaching County Hospital Vascular and Endovascular Surgery, Miskolc, Hungary., Diaz R; Estudios Clínicos Latinoamérica - Instituto Cardiovascular de Rosario, Rosario, Argentina., Brodmann M; Division of Angiology, Medical University of Graz, Graz, Austria., Muehlhofer E; Bayer AG, Research & Development, Wuppertal, Germany., Haskell LP; Janssen Research and Development, Raritan, New Jersey, USA., Bonaca MP; Colorado Prevention Center Clinical Research, Aurora, Colorado, USA.; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA. |
| Source: | Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 May; Vol. 20 (5), pp. 1193-1205. Date of Electronic Publication: 2022 Mar 07. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836 (Electronic) Linking ISSN: 15387836 NLM ISO Abbreviation: J Thromb Haemost Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
